Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$2.86 - $3.61 $82,482 - $104,112
-28,840 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$2.61 - $4.08 $7,041 - $11,007
-2,698 Reduced 8.55%
28,840 $99,000
Q4 2020

Feb 16, 2021

BUY
$1.82 - $2.61 $16,274 - $23,338
8,942 Added 39.57%
31,538 $79,000
Q3 2020

Nov 12, 2020

BUY
$2.02 - $3.02 $4,338 - $6,486
2,148 Added 10.5%
22,596 $48,000
Q2 2020

Aug 13, 2020

BUY
$2.12 - $3.22 $14,240 - $21,628
6,717 Added 48.92%
20,448 $46,000
Q1 2020

May 14, 2020

SELL
$1.82 - $3.87 $13,828 - $29,404
-7,598 Reduced 35.62%
13,731 $35,000
Q4 2019

Feb 14, 2020

BUY
$2.57 - $3.68 $24,988 - $35,780
9,723 Added 83.78%
21,329 $55,000
Q3 2019

Nov 14, 2019

SELL
$3.01 - $4.0 $67,077 - $89,140
-22,285 Reduced 65.75%
11,606 $40,000
Q2 2019

Aug 14, 2019

SELL
$2.79 - $4.31 $148,149 - $228,860
-53,100 Reduced 61.04%
33,891 $113,000
Q1 2019

May 15, 2019

SELL
$2.54 - $4.02 $101,147 - $160,084
-39,822 Reduced 31.4%
86,991 $236,000
Q4 2018

Feb 14, 2019

SELL
$2.46 - $4.2 $209,756 - $358,121
-85,267 Reduced 40.21%
126,813 $352,000
Q3 2018

Dec 21, 2021

BUY
$3.81 - $5.53 $44,203 - $64,159
11,602 Added 5.79%
212,080 $874,000
Q3 2018

Nov 14, 2018

SELL
$3.81 - $5.53 $632,795 - $918,466
-166,088 Reduced 45.31%
200,478 $824,000
Q2 2018

Apr 21, 2020

BUY
$5.06 - $6.78 $72,327 - $96,913
14,294 Added 4.06%
366,566 $1.9 Million
Q2 2018

Aug 14, 2018

SELL
$5.06 - $6.78 $260,215 - $348,668
-51,426 Reduced 12.74%
352,272 $1.83 Million
Q1 2018

Oct 18, 2019

BUY
$5.43 - $8.36 $55,945 - $86,133
10,303 Added 2.62%
403,698 $2.21 Million
Q1 2018

May 15, 2018

BUY
$5.43 - $8.36 $1.12 Million - $1.72 Million
205,401 Added 109.26%
393,395 $2.16 Million
Q4 2017

Feb 14, 2018

BUY
$8.15 - $10.55 $1.09 Million - $1.41 Million
133,176 Added 242.94%
187,994 $1.53 Million
Q3 2017

Nov 14, 2017

BUY
$10.45 - $11.44 $572,848 - $627,117
54,818
54,818 $572,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $52.6M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.